Home/Filings/3/0000899243-18-018443
3//SEC Filing

Omega Fund IV, L.P. 3

Accession 0000899243-18-018443

CIK 0001693415other

Filed

Jun 26, 8:00 PM ET

Accepted

Jun 27, 6:46 PM ET

Size

29.9 KB

Accession

0000899243-18-018443

Insider Transaction Report

Form 3
Period: 2018-06-27
Holdings
  • Series B Preferred Stock

    Common Stock (301,745 underlying)
  • Series A Preferred Stock

    (indirect: By Omega IV)
    Common Stock (450,004 underlying)
  • Series B Preferred Stock

    (indirect: By Omega IV)
    Common Stock (301,745 underlying)
  • Series B Preferred Stock

    Common Stock (360,022 underlying)
  • Series B Preferred Stock

    (indirect: By Omega V)
    Common Stock (360,022 underlying)
  • Series C Preferred Stock

    (indirect: By Omega V)
    Common Stock (54,391 underlying)
  • Series A Preferred Stock

    Common Stock (450,004 underlying)
  • Series C Preferred Stock

    Common Stock (227,429 underlying)
  • Series A Preferred Stock

    Common Stock (1,044,010 underlying)
  • Series C Preferred Stock

    Common Stock (54,391 underlying)
  • Series C Preferred Stock

    (indirect: By Omega IV)
    Common Stock (227,429 underlying)
  • Series A Preferred Stock

    (indirect: By Omega V)
    Common Stock (1,044,010 underlying)
Holdings
  • Series C Preferred Stock

    Common Stock (227,429 underlying)
  • Series A Preferred Stock

    Common Stock (450,004 underlying)
  • Series B Preferred Stock

    (indirect: By Omega IV)
    Common Stock (301,745 underlying)
  • Series C Preferred Stock

    Common Stock (54,391 underlying)
  • Series A Preferred Stock

    (indirect: By Omega IV)
    Common Stock (450,004 underlying)
  • Series B Preferred Stock

    Common Stock (301,745 underlying)
  • Series C Preferred Stock

    (indirect: By Omega IV)
    Common Stock (227,429 underlying)
  • Series A Preferred Stock

    Common Stock (1,044,010 underlying)
  • Series A Preferred Stock

    (indirect: By Omega V)
    Common Stock (1,044,010 underlying)
  • Series B Preferred Stock

    Common Stock (360,022 underlying)
  • Series B Preferred Stock

    (indirect: By Omega V)
    Common Stock (360,022 underlying)
  • Series C Preferred Stock

    (indirect: By Omega V)
    Common Stock (54,391 underlying)
Holdings
  • Series A Preferred Stock

    Common Stock (450,004 underlying)
  • Series B Preferred Stock

    Common Stock (301,745 underlying)
  • Series A Preferred Stock

    (indirect: By Omega IV)
    Common Stock (450,004 underlying)
  • Series B Preferred Stock

    (indirect: By Omega IV)
    Common Stock (301,745 underlying)
  • Series C Preferred Stock

    Common Stock (227,429 underlying)
  • Series C Preferred Stock

    (indirect: By Omega IV)
    Common Stock (227,429 underlying)
  • Series A Preferred Stock

    Common Stock (1,044,010 underlying)
  • Series B Preferred Stock

    (indirect: By Omega V)
    Common Stock (360,022 underlying)
  • Series C Preferred Stock

    (indirect: By Omega V)
    Common Stock (54,391 underlying)
  • Series A Preferred Stock

    (indirect: By Omega V)
    Common Stock (1,044,010 underlying)
  • Series B Preferred Stock

    Common Stock (360,022 underlying)
  • Series C Preferred Stock

    Common Stock (54,391 underlying)
Holdings
  • Series C Preferred Stock

    (indirect: By Omega V)
    Common Stock (54,391 underlying)
  • Series A Preferred Stock

    Common Stock (450,004 underlying)
  • Series B Preferred Stock

    Common Stock (301,745 underlying)
  • Series B Preferred Stock

    (indirect: By Omega IV)
    Common Stock (301,745 underlying)
  • Series C Preferred Stock

    (indirect: By Omega IV)
    Common Stock (227,429 underlying)
  • Series B Preferred Stock

    Common Stock (360,022 underlying)
  • Series A Preferred Stock

    Common Stock (1,044,010 underlying)
  • Series A Preferred Stock

    (indirect: By Omega V)
    Common Stock (1,044,010 underlying)
  • Series A Preferred Stock

    (indirect: By Omega IV)
    Common Stock (450,004 underlying)
  • Series C Preferred Stock

    Common Stock (227,429 underlying)
  • Series B Preferred Stock

    (indirect: By Omega V)
    Common Stock (360,022 underlying)
  • Series C Preferred Stock

    Common Stock (54,391 underlying)
Holdings
  • Series C Preferred Stock

    (indirect: By Omega IV)
    Common Stock (227,429 underlying)
  • Series A Preferred Stock

    Common Stock (450,004 underlying)
  • Series B Preferred Stock

    Common Stock (301,745 underlying)
  • Series A Preferred Stock

    (indirect: By Omega IV)
    Common Stock (450,004 underlying)
  • Series A Preferred Stock

    Common Stock (1,044,010 underlying)
  • Series C Preferred Stock

    Common Stock (227,429 underlying)
  • Series B Preferred Stock

    Common Stock (360,022 underlying)
  • Series C Preferred Stock

    Common Stock (54,391 underlying)
  • Series A Preferred Stock

    (indirect: By Omega V)
    Common Stock (1,044,010 underlying)
  • Series B Preferred Stock

    (indirect: By Omega IV)
    Common Stock (301,745 underlying)
  • Series B Preferred Stock

    (indirect: By Omega V)
    Common Stock (360,022 underlying)
  • Series C Preferred Stock

    (indirect: By Omega V)
    Common Stock (54,391 underlying)
Holdings
  • Series A Preferred Stock

    (indirect: By Omega V)
    Common Stock (1,044,010 underlying)
  • Series B Preferred Stock

    Common Stock (360,022 underlying)
  • Series C Preferred Stock

    Common Stock (54,391 underlying)
  • Series A Preferred Stock

    Common Stock (450,004 underlying)
  • Series B Preferred Stock

    (indirect: By Omega IV)
    Common Stock (301,745 underlying)
  • Series B Preferred Stock

    (indirect: By Omega V)
    Common Stock (360,022 underlying)
  • Series A Preferred Stock

    (indirect: By Omega IV)
    Common Stock (450,004 underlying)
  • Series C Preferred Stock

    (indirect: By Omega IV)
    Common Stock (227,429 underlying)
  • Series A Preferred Stock

    Common Stock (1,044,010 underlying)
  • Series C Preferred Stock

    (indirect: By Omega V)
    Common Stock (54,391 underlying)
  • Series B Preferred Stock

    Common Stock (301,745 underlying)
  • Series C Preferred Stock

    Common Stock (227,429 underlying)
Nessi Claudio
10% Owner
Holdings
  • Series A Preferred Stock

    Common Stock (450,004 underlying)
  • Series B Preferred Stock

    (indirect: By Omega IV)
    Common Stock (301,745 underlying)
  • Series C Preferred Stock

    Common Stock (227,429 underlying)
  • Series A Preferred Stock

    Common Stock (1,044,010 underlying)
  • Series A Preferred Stock

    (indirect: By Omega V)
    Common Stock (1,044,010 underlying)
  • Series B Preferred Stock

    Common Stock (360,022 underlying)
  • Series C Preferred Stock

    Common Stock (54,391 underlying)
  • Series A Preferred Stock

    (indirect: By Omega IV)
    Common Stock (450,004 underlying)
  • Series B Preferred Stock

    Common Stock (301,745 underlying)
  • Series B Preferred Stock

    (indirect: By Omega V)
    Common Stock (360,022 underlying)
  • Series C Preferred Stock

    (indirect: By Omega V)
    Common Stock (54,391 underlying)
  • Series C Preferred Stock

    (indirect: By Omega IV)
    Common Stock (227,429 underlying)
Holdings
  • Series A Preferred Stock

    Common Stock (450,004 underlying)
  • Series C Preferred Stock

    Common Stock (227,429 underlying)
  • Series A Preferred Stock

    Common Stock (1,044,010 underlying)
  • Series A Preferred Stock

    (indirect: By Omega V)
    Common Stock (1,044,010 underlying)
  • Series B Preferred Stock

    Common Stock (301,745 underlying)
  • Series C Preferred Stock

    (indirect: By Omega IV)
    Common Stock (227,429 underlying)
  • Series B Preferred Stock

    Common Stock (360,022 underlying)
  • Series B Preferred Stock

    (indirect: By Omega V)
    Common Stock (360,022 underlying)
  • Series C Preferred Stock

    Common Stock (54,391 underlying)
  • Series C Preferred Stock

    (indirect: By Omega V)
    Common Stock (54,391 underlying)
  • Series A Preferred Stock

    (indirect: By Omega IV)
    Common Stock (450,004 underlying)
  • Series B Preferred Stock

    (indirect: By Omega IV)
    Common Stock (301,745 underlying)
Holdings
  • Series A Preferred Stock

    Common Stock (450,004 underlying)
  • Series A Preferred Stock

    (indirect: By Omega IV)
    Common Stock (450,004 underlying)
  • Series B Preferred Stock

    Common Stock (301,745 underlying)
  • Series B Preferred Stock

    (indirect: By Omega IV)
    Common Stock (301,745 underlying)
  • Series C Preferred Stock

    Common Stock (227,429 underlying)
  • Series A Preferred Stock

    Common Stock (1,044,010 underlying)
  • Series B Preferred Stock

    Common Stock (360,022 underlying)
  • Series B Preferred Stock

    (indirect: By Omega V)
    Common Stock (360,022 underlying)
  • Series C Preferred Stock

    (indirect: By Omega V)
    Common Stock (54,391 underlying)
  • Series A Preferred Stock

    (indirect: By Omega V)
    Common Stock (1,044,010 underlying)
  • Series C Preferred Stock

    (indirect: By Omega IV)
    Common Stock (227,429 underlying)
  • Series C Preferred Stock

    Common Stock (54,391 underlying)
Holdings
  • Series C Preferred Stock

    Common Stock (227,429 underlying)
  • Series A Preferred Stock

    (indirect: By Omega IV)
    Common Stock (450,004 underlying)
  • Series B Preferred Stock

    Common Stock (301,745 underlying)
  • Series B Preferred Stock

    (indirect: By Omega V)
    Common Stock (360,022 underlying)
  • Series C Preferred Stock

    (indirect: By Omega V)
    Common Stock (54,391 underlying)
  • Series B Preferred Stock

    (indirect: By Omega IV)
    Common Stock (301,745 underlying)
  • Series B Preferred Stock

    Common Stock (360,022 underlying)
  • Series A Preferred Stock

    Common Stock (450,004 underlying)
  • Series C Preferred Stock

    (indirect: By Omega IV)
    Common Stock (227,429 underlying)
  • Series A Preferred Stock

    (indirect: By Omega V)
    Common Stock (1,044,010 underlying)
  • Series C Preferred Stock

    Common Stock (54,391 underlying)
  • Series A Preferred Stock

    Common Stock (1,044,010 underlying)
Footnotes (5)
  • [F1]The Series A Preferred Stock is convertible into Common Stock on a 5.5555-for-one basis into the number of shares of Common Stock shown in Column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares have no expiration date.
  • [F2]The Series B Preferred Stock is convertible into Common Stock on a 5.5555-for-one basis into the number of shares of Common Stock shown in Column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares have no expiration date.
  • [F3]The Series C Preferred Stock is convertible into Common Stock on a 5.5555-for-one basis into the number of shares of Common Stock shown in Column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares have no expiration date.
  • [F4]The reported securities are beneficially owned by Omega Fund IV GP, L.P. ("Omega IV GP"), as general partner of Omega Fund IV, L.P. ("Omega IV"). Omega Fund IV G.P. Manager, Ltd. ("Omega IV GP Manager"), is the general partner of Omega IV GP. Otello Stampacchia, Richard Lim and Anne-Mari Paster are all the shareholders and directors of Omega IV GP Manager and have shared voting and investment power over the shares held by Omega IV. Each of the Reporting Persons disclaim beneficial ownership of these securities, except to the extent of his, her or its pecuniary interest therein, if any.
  • [F5]The reported securities are beneficially owned by Omega Fund V GP, L.P. ("Omega V GP"), as general partner of Omega Fund V, L.P. ("Omega V"). Omega Fund V GP Manager, Ltd. ("Omega V GP Manager"), is the general partner of Omega V GP. Otello Stampacchia, Richard Lim, Anne-Mari Paster and Claudio Nessi are all the shareholders and directors of Omega V GP Manager and have shared voting and investment power over the shares held by Omega V. Each of the Reporting Persons disclaim beneficial ownership of these securities, except to the extent of his, her or its pecuniary interest therein, if any.

Issuer

Translate Bio, Inc.

CIK 0001693415

Entity typeother
IncorporatedCayman Islands

Related Parties

1
  • filerCIK 0001528382

Filing Metadata

Form type
3
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 6:46 PM ET
Size
29.9 KB